Arsenic-induced sub-lethal stress reprograms human bronchial epithelial cells to CD61- cancer stem cells

Oncotarget

Volumn 5, Issue 5, 2014, Pages 1290-1303

  Chang, Qingshan ^a   Chen, Bailing ^a   Thakur, Chitra ^a   Lu, Yongju ^a   Chen, Fei ^a  

^a WAYNE STATE UNIVERSITY   (United States)

Author keywords

Arsenic; Cancer stem cells; JNK; Self renewal; Sub lethal stress

Indexed keywords

ARSENIC; BETA3 INTEGRIN; KRUPPEL LIKE FACTOR 4; MYC PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR SOX2; INTERLEUKIN 2 RECEPTOR; ITGB3 PROTEIN, HUMAN; KRUPPEL LIKE FACTOR; POU5F1 PROTEIN, HUMAN; SOX2 PROTEIN, HUMAN; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR SOX;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; BRONCHIAL EPITHELIAL CELL; BRONCHUS MUCOSA; CANCER PROGNOSIS; CANCER STEM CELL; CANCER SURVIVAL; CARCINOGENICITY; CELL DIFFERENTIATION; CONTROLLED STUDY; DNA REPAIR; GENE EXPRESSION; HUMAN; HUMAN CELL; LUNG CANCER; MALE; METASTASIS; MOUSE; NONHUMAN; OVARY CANCER; OXIDATIVE PHOSPHORYLATION; STRESS; SUBLETHAL STRESS; ANIMAL; BAGG ALBINO MOUSE; BREAST TUMOR; BRONCHUS; CELL LINE; CELL TRANSFORMATION; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; EPITHELIUM; EXPERIMENTAL NEOPLASM; FEMALE; GENE SILENCING; GENETICS; LUNG TUMOR; METABOLISM; MORTALITY; MULTICELLULAR SPHEROID; NONOBESE DIABETIC MOUSE; NUCLEAR REPROGRAMMING; ONCOGENE MYC; OVARY TUMOR; PATHOLOGY; PHENOTYPE; PHOSPHORYLATION; PHYSIOLOGICAL STRESS; SCID MOUSE; SECONDARY; SURVIVAL RATE; TOXICITY;

ANIMALS; ARSENIC; BREAST NEOPLASMS; BRONCHI; CELL LINE; CELL TRANSFORMATION, NEOPLASTIC; CELLULAR REPROGRAMMING; DNA REPAIR; EPITHELIUM; FEMALE; GENE EXPRESSION; GENE KNOCKDOWN TECHNIQUES; GENES, MYC; HUMANS; INTEGRIN BETA3; JNK MITOGEN-ACTIVATED PROTEIN KINASES; KRUPPEL-LIKE TRANSCRIPTION FACTORS; LUNG NEOPLASMS; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED NOD; MICE, SCID; NEOPLASMS, EXPERIMENTAL; NEOPLASTIC STEM CELLS; OCTAMER TRANSCRIPTION FACTOR-3; OVARIAN NEOPLASMS; PHENOTYPE; PHOSPHORYLATION; RECEPTORS, INTERLEUKIN-2; SOXB1 TRANSCRIPTION FACTORS; SPHEROIDS, CELLULAR; STRESS, PHYSIOLOGICAL; SURVIVAL RATE;

EID: 84898645545     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.1789     Document Type: Article

References (46)

1. Kitchin KT and Conolly R. Arsenic-induced carcinogenesis--oxidative stress as a possible mode of action and future research needs for more biologically based risk assessment. Chemical research in toxicology. 2010; 23(2):327-335.
2. Thomas DJ. Molecular processes in cellular arsenic metabolism. Toxicology and applied pharmacology. 2007; 222(3):365-373.
3. Nordstrom DK. Public health. Worldwide occurrences of arsenic in ground water. Science (New York, NY. 2002; 296(5576):2143-2145.
4. Beezhold K, Liu J, Kan H, Meighan T, Castranova V, Shi X and Chen F. miR-190-mediated downregulation of PHLPP contributes to arsenic-induced Akt activation and carcinogenesis. Toxicol Sci. 2011; 123(2):411-420.
5. Chen B, Liu J, Chang Q, Beezhold K, Lu Y and Chen F. JNK and STAT3 signaling pathways converge on Aktmediated phosphorylation of EZH2 in bronchial epithelial cells induced by arsenic. Cell Cycle. 2013; 12(1):112-121.
6. Tokar EJ, Qu W, Liu J, Liu W, Webber MM, Phang JM and Waalkes MP. Arsenic-specific stem cell selection during malignant transformation. J Natl Cancer Inst. 2010; 102(9):638-649.
7. Xu Y, Tokar EJ, Sun Y and Waalkes MP. Arsenictransformed malignant prostate epithelia can convert noncontiguous normal stem cells into an oncogenic phenotype. Environmental health perspectives. 2012; 120(6):865-871.
8. Reya T, Morrison SJ, Clarke MF and Weissman IL. Stem cells, cancer, and cancer stem cells. Nature. 2001; 414(6859):105-111.
9. Clarke MF, Dick JE, Dirks PB, Eaves CJ, Jamieson CH, Jones DL, Visvader J, Weissman IL and Wahl GM. Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer research. 2006; 66(19):9339-9344.
10. Kemper K, Grandela C and Medema JP. Molecular identification and targeting of colorectal cancer stem cells. Oncotarget. 2010; 1(6):387-395.
11. Blagosklonny MV. NCI's provocative questions on cancer: some answers to ignite discussion. Oncotarget. 2011; 2(12):1352-1367.
12. Bonnet D and Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nature medicine. 1997; 3(7):730-737.
13. Lapidot T, Sirard C, Vormoor J, Murdoch B, Hoang T, Caceres-Cortes J, Minden M, Paterson B, Caligiuri MA and Dick JE. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature. 1994; 367(6464):645-648.
14. Visvader JE and Lindeman GJ. Cancer stem cells: current status and evolving complexities. Cell stem cell. 2012; 10(6):717-728.
15. Medema JP. Cancer stem cells: The challenges ahead. Nature cell biology. 2013; 15(4):338-344.
16. Chang Q, Pan J, Wang X, Zhang Z, Chen F and Shi X. Reduced reactive oxygen species-generating capacity contributes to the enhanced cell growth of arsenictransformed epithelial cells. Cancer research. 2010; 70(12):5127-5135.
17. Yamashita YM, Mahowald AP, Perlin JR and Fuller MT. Asymmetric inheritance of mother versus daughter centrosome in stem cell division. Science. 2007; 315(5811):518-521.
18. Ben-Porath I, Thomson MW, Carey VJ, Ge R, Bell GW, Regev A and Weinberg RA. An embryonic stem celllike gene expression signature in poorly differentiated aggressive human tumors. Nature genetics. 2008; 40(5):499-507.
19. Magee JA, Piskounova E and Morrison SJ. Cancer stem cells: impact, heterogeneity, and uncertainty. Cancer cell. 2012; 21(3):283-296.
20. Roy S and Majumdar AP. Signaling in colon cancer stem cells. Journal of molecular signaling. 2012; 7(1):11.
21. Chen F, Lu Y, Zhang Z, Vallyathan V, Ding M, Castranova V and Shi X. Opposite effect of NF-kappa B and c-Jun N-terminal kinase on p53-independent GADD45 induction by arsenite. The Journal of biological chemistry. 2001; 276(14):11414-11419.
22. Chen F, Castranova V, Li Z, Karin M and Shi X. Inhibitor of nuclear factor kappaB kinase deficiency enhances oxidative stress and prolongs c-Jun NH2-terminal kinase activation induced by arsenic. Cancer research. 2003; 63(22):7689-7693.
23. Hui L, Zatloukal K, Scheuch H, Stepniak E and Wagner EF. Proliferation of human HCC cells and chemically induced mouse liver cancers requires JNK1-dependent p21 downregulation. J Clin Invest. 2008; 118(12):3943-3953.
24. Gyorffy B, Lanczky A, Eklund AC, Denkert C, Budczies J, Li Q and Szallasi Z. An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients. Breast Cancer Res Treat. 2010; 123(3):725-731.
25. Celik I, Gallicchio L, Boyd K, Lam TK, Matanoski G, Tao X, Shiels M, Hammond E, Chen L, Robinson KA, Caulfield LE, Herman JG, Guallar E and Alberg AJ. Arsenic in drinking water and lung cancer: a systematic review. Environ Res. 2008; 108(1):48-55.
26. Putila JJ and Guo NL. Association of arsenic exposure with lung cancer incidence rates in the United States. PLoS One. 2011; 6(10):e25886.
27. Liu J, Chen B, Lu Y, Guan Y and Chen F. JNK-Dependent Stat3 Phosphorylation Contributes to Akt Activation in Response to Arsenic Exposure. Toxicol Sci. 2012; 129(2):363-371.
28. Chen B, Liu J, Chang Q, Beezhold K, Lu Y and Chen F. JNK and STAT3 signaling pathways converge on Aktmediated phosphorylation of EZH2 in bronchial epithelial cells induced by arsenic. Cell Cycle. 2013; 12(1).
29. Waalkes MP, Liu J, Germolec DR, Trempus CS, Cannon RE, Tokar EJ, Tennant RW, Ward JM and Diwan BA. Arsenic exposure in utero exacerbates skin cancer response in adulthood with contemporaneous distortion of tumor stem cell dynamics. Cancer research. 2008; 68(20):8278-8285.
30. Sun Y, Tokar EJ and Waalkes MP. Overabundance of putative cancer stem cells in human skin keratinocyte cells malignantly transformed by arsenic. Toxicol Sci. 2012; 125(1):20-29.
31. Tokar EJ, Diwan BA and Waalkes MP. Arsenic exposure transforms human epithelial stem/progenitor cells into a cancer stem-like phenotype. Environmental health perspectives. 2010; 118(1):108-115.
32. Tokar EJ, Person RJ, Sun Y, Perantoni AO and Waalkes MP. Chronic Exposure of Renal Stem Cells to Inorganic Arsenic Induces a Cancer Phenotype. Chem Res Toxicol. 2013; 26:96.
33. Tokar EJ, Diwan BA, Ward JM, Delker DA and Waalkes MP. Carcinogenic effects of "whole-life" exposure to inorganic arsenic in CD1 mice. Toxicol Sci. 2011; 119(1)73-83
34. Zeidler M, Varambally S, Cao Q, Chinnaiyan AM, Ferguson DO, Merajver SD and Kleer CG. The Polycomb group protein EZH2 impairs DNA repair in breast epithelial cells. Neoplasia. 2005; 7(11):1011-1019.
35. Chang CJ, Yang JY, Xia W, Chen CT, Xie X, Chao CH, Woodward WA, Hsu JM, Hortobagyi GN and Hung MC. EZH2 promotes expansion of breast tumor initiating cells through activation of RAF1-beta-catenin signaling. Cancer Cell. 2011; 19(1):86-100.
36. Shyh-Chang N, Zheng Y, Locasale JW and Cantley LC. Human pluripotent stem cells decouple respiration from energy production. The EMBO journal. 2011; 30(24):4851-4852.
37. Solozobova V and Blattner C. p53 in stem cells. World J Biol Chem. 2011; 2(9):202-214.
38. Folmes CD, Nelson TJ, Martinez-Fernandez A, Arrell DK, Lindor JZ, Dzeja PP, Ikeda Y, Perez-Terzic C and Terzic A. Somatic oxidative bioenergetics transitions into pluripotency-dependent glycolysis to facilitate nuclear reprogramming. Cell metabolism. 2011; 14(2):264-271.
39. Panopoulos AD and Izpisua Belmonte JC. Anaerobicizing into pluripotency. Cell metabolism. 2011; 14(2):143-144.
40. Teperino R, Amann S, Bayer M, McGee SL, Loipetzberger A, Connor T, Jaeger C, Kammerer B, Winter L, Wiche G, Dalgaard K, Selvaraj M, Gaster M, Lee-Young RS, Febbraio MA, Knauf C, et al. Hedgehog partial agonism drives Warburg-like metabolism in muscle and brown fat. Cell. 2012; 151(2):414-426.
41. Fan Y, Dickman KG and Zong WX. Akt and c-Myc differentially activate cellular metabolic programs and prime cells to bioenergetic inhibition. J Biol Chem. 2010; 285(10):7324-7333.
42. Vaillant F, Asselin-Labat ML, Shackleton M, Forrest NC, Lindeman GJ and Visvader JE. The mammary progenitor marker CD61/beta3 integrin identifies cancer stem cells in mouse models of mammary tumorigenesis. Cancer research. 2008; 68(19):7711-7717.
43. Leccia F, Nardone A, Corvigno S, Vecchio LD, De Placido S, Salvatore F and Veneziani BM. Cytometric and biochemical characterization of human breast cancer cells reveals heterogeneous myoepithelial phenotypes. Cytometry Part A : the journal of the International Society for Analytical Cytology. 2012; 81(11):960-972.
44. Mead MN. Arsenic: in search of an antidote to a global poison. Environmental health perspectives. 2005; 113(6):A378-386.
45. Obokata H, Wakayama T, Sasai Y, Kojima K, Vacanti MP, Niwa H, Yamato M and Vacanti CA. Stimulus-triggered fate conversion of somatic cells into pluripotency. Nature. 2014; 505(7485):641-647.
46. Obokata H, Sasai Y, Niwa H, Kadota M, Andrabi M, Takata N, Tokoro M, Terashita Y, Yonemura S, Vacanti CA and Wakayama T. Bidirectional developmental potential in reprogrammed cells with acquired pluripotency. Nature. 2014; 505(7485):676-680.